Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.
作者信息
Clementi M, Menzo S, Bagnarelli P, Valenza A, Paolucci S, Sampaolesi R, Manzin A, Varaldo P E
机构信息
Dipartimento di Scienze Biomediche, Università di Trieste, Italy.
出版信息
Clin Microbiol Rev. 1996 Apr;9(2):135-47. doi: 10.1128/CMR.9.2.135.
Abstract
摘要
相似文献
1
Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.定量分子方法在研究1型人类免疫缺陷病毒感染中的临床应用。
Clin Microbiol Rev. 1996 Apr;9(2):135-47. doi: 10.1128/CMR.9.2.135.
2
Viral dynamics in human immunodeficiency virus type 1 infection.1型人类免疫缺陷病毒感染中的病毒动力学
Nature. 1995 Jan 12;373(6510):117-22. doi: 10.1038/373117a0.
3
[HIV infection].
Rev Prat. 2012 Feb;62(2):255-62.
4
Diagnosis of HIV infection and laboratory monitoring of its therapy.HIV感染的诊断及其治疗的实验室监测。
J Clin Virol. 2001 Jun;21(3):187-96. doi: 10.1016/s1386-6532(01)00165-2.
5
The gag proteins of human immunodeficiency virus type 1: mechanisms of virus assembly and possibilities for interference.1型人类免疫缺陷病毒的 gag 蛋白：病毒组装机制及干扰可能性
Med Microbiol Immunol. 1994 Sep;183(4):177-94. doi: 10.1007/BF00194171.
6
Turnover of circulating virion RNA and of cell-associated viral DNA reflects active viral replication in human immunodeficiency virus type 1-infected individuals.循环病毒粒子RNA和细胞相关病毒DNA的周转反映了1型人类免疫缺陷病毒感染个体中的活跃病毒复制。
J Virol. 1995 Apr;69(4):2637-9. doi: 10.1128/JVI.69.4.2637-2639.1995.
7
Cellular fatty acid synthase is required for late stages of HIV-1 replication.细胞脂肪酸合酶是 HIV-1 复制后期所必需的。
Retrovirology. 2017 Sep 29;14(1):45. doi: 10.1186/s12977-017-0368-z.
8
Toward a durable treatment of HIV-1 infection using RNA interference.利用 RNA 干扰实现 HIV-1 感染的持久治疗。
Prog Mol Biol Transl Sci. 2011;102:141-63. doi: 10.1016/B978-0-12-415795-8.00001-5.
9
[Application of confocal microscopy to the use of a study of the morphogenesis of human immunodeficiency virus type 1].
Vopr Virusol. 2008 May-Jun;53(3):4-8.
10
Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention.
Hum Gene Ther. 1994 Aug;5(8):927-39. doi: 10.1089/hum.1994.5.8-927.
引用本文的文献
1
Comparison of analytic methods for quantitative real-time polymerase chain reaction data.定量实时聚合酶链反应数据的分析方法比较
J Comput Biol. 2015 Nov;22(11):988-96. doi: 10.1089/cmb.2015.0023. Epub 2015 Jul 23.
2
Factors associated with HIV-1 proviral DNA loads in patients with undetectable plasma RNA load.血浆RNA载量检测不到的患者中与HIV-1前病毒DNA载量相关的因素。
J Korean Med Sci. 2009 Feb;24(1):152-4. doi: 10.3346/jkms.2009.24.1.152. Epub 2009 Feb 28.
3
Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system.中枢神经系统病毒性疾病中脑脊液的分子分析。
J Clin Virol. 2003 Jan;26(1):1-28. doi: 10.1016/s1386-6532(02)00173-7.
4
Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR.使用实时聚合酶链反应对2型人类免疫缺陷病毒A和B亚型的前病毒载量进行定量分析。
J Clin Microbiol. 2001 Dec;39(12):4264-8. doi: 10.1128/JCM.39.12.4264-4268.2001.
5
Quantitative molecular analysis of virus expression and replication.病毒表达与复制的定量分子分析
J Clin Microbiol. 2000 Jun;38(6):2030-6. doi: 10.1128/JCM.38.6.2030-2036.2000.
6
Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay.运用定量竞争聚合酶链反应分析法对外周血单个核细胞中的2型人类免疫缺陷病毒DNA进行定量分析。
J Clin Microbiol. 1999 Feb;37(2):453-6. doi: 10.1128/JCM.37.2.453-456.1999.
7
Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy.比较QUANTIPLEX HIV-1 RNA 2.0检测法与AMPLICOR HIV-1 MONITOR 1.0检测法对接受司他夫定-去羟肌苷联合治疗患者血浆中人类免疫缺陷病毒1型RNA水平的定量检测。
J Clin Microbiol. 1998 Nov;36(11):3392-5. doi: 10.1128/JCM.36.11.3392-3395.1998.
8
Quantitation of cytomegalovirus: methodologic aspects and clinical applications.巨细胞病毒的定量分析：方法学方面及临床应用
Clin Microbiol Rev. 1998 Jul;11(3):533-54. doi: 10.1128/CMR.11.3.533.
9
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo.1型人类免疫缺陷病毒转录本在体外和体内的动态变化及调控
J Virol. 1996 Nov;70(11):7603-13. doi: 10.1128/JVI.70.11.7603-7613.1996.
本文引用的文献
1
Advanced methods in PCR product detection.聚合酶链式反应（PCR）产物检测的先进方法。
PCR Methods Appl. 1994 Aug;4(1):S1-14. doi: 10.1101/gr.4.1.s1.
2
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection.初次感染时对1型人类免疫缺陷病毒外膜蛋白中特定序列的选择。
J Virol. 1993 Jun;67(6):3345-56. doi: 10.1128/JVI.67.6.3345-3356.1993.
3
How does HIV cause AIDS?艾滋病病毒是如何引发艾滋病的？
Science. 1993 May 28;260(5112):1273-9. doi: 10.1126/science.8493571.
4
Detection of HIV-1 distribution in different blood fractions by two nucleic acid amplification assays.通过两种核酸扩增检测法检测HIV-1在不同血液成分中的分布情况。
AIDS Res Hum Retroviruses. 1993 Mar;9(3):259-65. doi: 10.1089/aid.1993.9.259.
5
Pathogenesis of human immunodeficiency virus infection.人类免疫缺陷病毒感染的发病机制
Microbiol Rev. 1993 Mar;57(1):183-289. doi: 10.1128/mr.57.1.183-289.1993.
6
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.在疾病的临床潜伏期，HIV感染在淋巴组织中活跃且呈进行性发展。
Nature. 1993 Mar 25;362(6418):355-8. doi: 10.1038/362355a0.
7
Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species.用于准确定量HIV DNA和RNA种类的定量竞争性聚合酶链反应。
Biotechniques. 1993 Jan;14(1):70-81.
8
9
Genotypic and phenotypic characterization of HIV-1 patients with primary infection.初次感染HIV-1患者的基因和表型特征
Science. 1993 Aug 27;261(5125):1179-81. doi: 10.1126/science.8356453.
10
Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection.人类免疫缺陷病毒1型（HIV-1）初次感染期间HIV-1 DNA和RNA合成的动力学
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6405-9. doi: 10.1073/pnas.90.14.6405.
Zotero 插件